News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Settles with Teva Pharmaceutical Industries Limited (TEVA) Over Lipitor in UK; Deal Keeps Generic Lipitor at Bay to May 2012


10/11/2011 8:09:27 AM

Pfizer Inc. announced today that the company has settled its patent-infringement case against Teva and several other parties in respect of Teva's generic form of Lipitor in the U.K. Under the terms of the settlement agreement Teva and the other settling parties agree not to sell Teva's atorvastatin product in the U.K. before patent expiry in May of 2012. Teva acknowledges that Pfizer's Lipitor patent is valid and infringed by Teva's product. Other terms of the settlement remain confidential.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES